Neural Cell News Volume 16.32 | Aug 17 2022

    0
    34








    2022-08-17 | NCN 16.32


    Neural Cell News by STEMCELL Technologies
    Vol. 16.32 – 17 August, 2022
    TOP STORY

    A CRISPRi/a Platform in Human iPSC-Derived Microglia Uncovers Regulators of Disease States

    Scientists present a screening platform to systematically elucidate functional consequences of genetic perturbations in human induced pluripotent stem cell (iPSC)-derived microglia.
    [Nature Neuroscience]

    Full ArticlePress Release
    Register now for the VIB Neurotechnologies conference.
    PUBLICATIONSRanked by the impact factor of the journal

    Neuroblastoma Suppressor of Tumorigenicity 1 Is a Circulating Protein Associated with Progression to End-Stage Kidney Disease in Diabetes

    Using the SOMAscan proteomic platform, the authors measured concentrations of 25 TGF-β signaling family proteins in four different cohorts composed in total of 754 Caucasian or Pima Indian individuals with type 1 or type 2 diabetes.
    [Science Translational Medicine]

    Abstract

    Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma

    Researchers revealed that purinergic signaling in gliomas was shaped by genotype, lineage, and functional state, and that core enzymes expressed by tumor and myeloid cells were organized to promote adenosine-rich microenvironments potentially amenable to therapeutic targeting.
    [Nature Communications]

    Full Article

    Primary Cilia and SHH Signaling Impairments in Human and Mouse Models of Parkinson’s Disease

    Scientists observed a shortening of prostate cancer (PC). Scientists detected a shortening of PC in PINK1-deficient human cellular and mouse models of familial Parkinson’s disease.
    [Nature Communications]

    Full Article

    USP21 Promotes Self-Renewal and Tumorigenicity of Mesenchymal Glioblastoma Stem Cells by Deubiquitinating and Stabilizing FOXD1

    The authors identified the ubiquitin-specific peptidase 21 as a critical FOXD1 deubiquitinase in mesenchymal properties of glioblastoma stem cells.
    [Cell Death & Differentiation]

    Full Article

    The Telomere Maintenance Mechanism Spectrum and Its Dynamics in Gliomas

    Telomerase repeated amplification protocol and C-circle assays were used to profile and characterize the TMM cross-sectionally and temporally across glioma samples.
    [Genome Medicine]

    Full Article

    IDH1/2 Wildtype Gliomas Grade 2 and 3 with Molecular Glioblastoma-Like Profile Have a Distinct Course of Epilepsy Compared to IDH1/2 Wildtype Glioblastomas

    Investigators analyzed epilepsy data of an existing cohort including IDHwt histologically lower-grade glioma WHO grade 2 and 3 with molecular glioblastoma-like profile, IDHwt hLGG, and IDHwt glioblastoma patients.
    [Neuro-Oncology]

    Abstract

    APOE4 Drives Inflammation in Human Astrocytes via TAGLN3 Repression and NF-κB Activation

    Researchers uncovered that APOE4 specifically downregulated TAGLN3, involving histone deacetylases activity, which results in low-grade chronic inflammation and hyperactivated inflammatory responses.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Neuroinflammation in Neuronopathic Gaucher Disease: Role of Microglia and NK Cells, Biomarkers, and Response to Substrate Reduction Therapy

    Using single-cell resolution of mouse Neuronopathic Gaucher disease brains, lipidomics, and newly generated biomarkers, scientists found induction of neuroinflammation pathways involving microglia, NK cells, astrocytes, and neurons.
    [eLife]

    Full Article

    Natural Variants of Human SARM1 Cause Both Intrinsic and Dominant Loss-of-Function Influencing Axon Survival

    Researchers investigated whether there were naturally occurring SARM1 alleles within the human population that encoded SARM1 variants with loss-of-function.
    [Scientific Reports]

    Full Article
    Virtual Poster Presentation: CRISPR-Cas9 Gene Editing of Cerebral Organoids to Model Microcephaly
    REVIEWS

    ER Stress and UPR in Alzheimer’s Disease: Mechanisms, Pathogenesis, Treatments

    Scientists aimed at deciphering the unique role of endoplasmic reticulum stress in Alzheimer’s disease (AD) pathogenesis, reviewing key findings, and existing controversy in an attempt to summarize plausible therapeutic interventions in the management of AD pathophysiology.
    [Cell Death & Disease]

    Full Article
    INDUSTRY AND POLICY NEWS

    Amylyx Pharmaceuticals Announces Partnership Agreement with Sunnybrook Research Institute to Identify Novel Drug Candidates for Neurodegenerative Diseases

    Amylyx Pharmaceuticals, Inc. announced a two-year sponsored research agreement with Sunnybrook Research Institute to expedite the identification of novel drug candidates that inhibit Bax and Bak for the development as therapeutics for neurodegenerative diseases.
    [Amylyx Pharmaceuticals, Inc. (BusinessWire, Inc.)]

    Press Release
    FEATURED EVENT

    3D Cell Culture Symposium

    1 December 2022
    Online

    > See All Events

    JOB OPPORTUNITIES

    Faculty Member – Faculty of Life and Health Sciences

    Shenzhen Institute of Advanced Technology – Shenzhen, China

    Research Associates – Center for Perioperative Organ Protection

    Duke University – Durham, North Carolina, United States

    Senior Investigator – Cancer Research

    NIH National Cancer Institute – Bethesda, Maryland, United States

    Research Project Coordinator – Biology

    Dalla Lana School of Public Health – Toronto, Ontario, Canada

    Postdoctoral Researcher – Regenerative Medicine

    National University of Ireland Galway – Galway, Ireland

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Neural Cell News Twitter